Surgery versus chemotherapy for early-stage small cell esophageal cancer
Part of Cancer, Digestive system clinical trials.
This study compares how well surgery works compared to chemotherapy and radiation for treating small cell cancer that started in the esophagus and hasn't spread far. Researchers will examine which approach helps patients live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with small cell cancer that originated in your esophagus (confirmed by biopsy)
- Your cancer is limited-stage, meaning it is confined to the esophagus and nearby lymph nodes with no spread to distant organs
- You received definitive treatment (either surgery, or chemotherapy combined with radiation) at the study hospital
- You are 18 years or older
- Your medical records include complete information about your diagnosis, treatment, and follow-up care
- You do not have any other active cancer diagnoses from the past 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests giving chemotherapy with immunotherapy, or chemotherapy with radiation, before surgery for esophageal cancer. The goal is to see which approach is better at shrinking the tumor and improving outcomes.
This trial tests a combination of three drugs — one immunotherapy (serplulimab) plus two chemotherapies (etoposide and cisplatin) — given before surgery to shrink esophageal cancer and improve outcomes. It is for patients with limited-stage small cell carcinoma of the esophagus that has not spread far.
This study compares two standard approaches for treating esophageal cancer before surgery: chemotherapy combined with radiation versus chemotherapy combined with immunotherapy. The goal is to see which approach works better for shrinking tumors and improving outcomes in patients whose cancer is considered removable.
This study compares two ways to treat cervical esophagus squamous cell cancer: surgery alone versus chemo-radiation (chemotherapy plus radiation). It may help find the best approach to control the cancer while keeping side effects manageable.
This trial studies whether adding chemotherapy after surgery for esophageal squamous cell cancer can reduce the chance the cancer returns. It focuses on people whose surgery removed cancerous lymph nodes and who are healthy enough to tolerate chemotherapy.
This study tests a combination of an immunotherapy drug (adebrelimab) plus chemotherapy and radiation for esophageal small cell carcinoma. The goal is to see if this combination improves outcomes for patients who have not been treated before.
Hear when a new Esophageal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.